HomeFlu VaccineIT (Shot) HoursAbout UsPollen CountsLinksContact Us

Click for Bio
Maria T. Olivero, M.D.

Click for Bio
Brett E. Stanaland, M.D.


Allergy care you can trust.  We are Board Certified by the American Board of Allergy and Immunology (www.ABAI.org) and are actively involved in Maintaince of Certification (MOC).

Our practice has served the Naples Community since 1995.

We have helped thousands of patients TAKE CONTROL of their allergies by having years of speciality training in the diagnosis and treatment of:

  • Asthma
  • Respiratory Allergy
  • Hayfever
  • Allergic Conjunctivitis
  • Sinus Disease
  • Eczema
  • Urticaria
  • Chronic Cough
  • Insect Allergy
  • Anaphylaxis
  • Food and Drug Allergies
  • Immune Deficiencies 

Accepting new patients.

Call for an appointment 239-434-6200 



Thursday, September 28, 2017

Allergy Problems Post Hurricane Irma
Hurricane Irma has caused its destruction, but unfortunately for those with allergies this may only be the beginning of their problems. Excessive flooding that followed Irma could cause increased exposure to indoor mold. For patients with allergies this could mean, increased respiratory symptoms of sneezing, cough, congestion as well as a surge of infections such as sinusitis, bronchitis and even pneumonia. Approximately one third of patients with allergies are sensitive to mold. Mold can even cause patients without allergies to have respiratory problems as well. Those with compromised immune systems or severe lung disease with COPD or asthma are at greater risk of severe health problems, including pneumonia, which may be caused by mold. We may also see a spike in pollen allergies due to the excessive moisture left by the storm. It is important for patients to get tested to see if they have allergies to help them avoid problems. If positive, avoidance measures and appropriate medications can protect them from the onslaught of what is soon to come.
7:57 am edt 

Tuesday, August 22, 2017

New Treatment Available for Atopic Dermatitis
Great news for adult patients with moderate to severe atopic dermatitis. There is a new treatment available.. Dupixent! This is a monoclonal antibody that binds and inhibits interleukin-4 receptor alpha subunit, interfering with interleukin-4 and interleukin-13 cytokines, reducing inflammation and altering immune responsiveness. Directed biologic therapy to the underlying cause of this severe frustrating disease.
8:30 am edt 

2017.09.01 | 2017.08.01

Link to web log's RSS file

Full name:
Email address:
Type message here: